* Oventus devices may offer a suitable treatment to those who cannot tolerate Continuous Positive Airway Pressure (CPAP) therapy. Oral devices are not generally accepted as the first line treatment for sleep apnoea. Diagnosis and monitoring by a suitably qualified healthcare professional is required.
** Lavery D, Hart C et al. Safety and Efficacy of a Novel Oral Appliance in the Treatment of Obstructive Sleep Apnea. Journal of Dental Sleep Medicine Vol.4 No.3 July 2017
Welcome to the unique alternative for snorers and sufferers of mild-to-moderate obstructive sleep apnoea (OSA). The Oventus Treatment Platform may also offer a suitable alternative to those who cannot tolerate Continuous Positive Airway Pressure (CPAP). OSA is a serious condition, so speak to your healthcare professional for a diagnosis and to discuss if an oral device could help you.
An Oventus clinical trial showed that 100% of patients experienced a significant reduction in snoring with 82% eliminating snoring completely and 76% reducing their Apnoea Hypopnea Index (AHI) by more than half.**
Now is the time to explore the possibility that this treatment could really work for you.
Call 1300 533 159 or register online
Take our Sleep Apnoea quiz
Wake up feeling tired? This quiz could change things for you.Click FOR THE QUICK QUIZ
SLEEP® journal paper shows Oventus ExVent and OnePAP valves used in combination with mandibular advancement splints reduce sleep apnoea for a substantial proportion of patients
12 June 2019
Oventus Medical Ltd (ASX: OVN) is pleased to advise that a peer-reviewed paper on Oventus’ clinical data has been published in the scientific journal, SLEEP® […]Read more
Stockhead – Dr Boreham’s Crucible: how $18bn snore buster ResMed stacks up against ASX sleep minnows
8 February 2019
Small cap share analyst and business journalist, Tim Boreham covers companies operating the sleep treatment space. This Stockhead article includes a section on Oventus’ Sleep […]Read more